Streetbeat News

Revenues

AZTA

Azenta, Inc. (NASDAQ:AZTA) has announced a Memorandum of Understanding with the Ministry of Public Health of the DRC for a €100 million National Vaccination Service project. B Medical Systems, a part of Azenta, will provide cold chain solutions for vaccine storage and transport, including customized Toyota vehicles and other equipment. Over 50% of the project's value will be recognized as revenue for Azenta, with deliveries expected in fiscal 2024.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:32 pm

BITW

BLOK

GBTC

Crypto fund inflows have surpassed $1 billion in 2023, with Bitcoin, Ethereum, and Solana leading the charge. CoinShares reports a seven-week inflow streak, adding $293 million recently. Bitcoin investment products saw $240 million inflows, Ethereum had its highest inflows since August 2022 at $49.1 million, and Solana received $12.4 million. The upcoming Benzinga’s Future Of Digital Assets Event will discuss the potential impact of a Bitcoin ETF approval. Total assets under management are at their highest since May 2022, with a 9.6% increase over the past week and a 99% rise since the start of the year. Bitcoin ETPs and blockchain equity ETFs also saw significant inflows. Regionally, Canada leads in inflows, followed by the U.S., Germany, and Switzerland. Bitcoin's price was up 5%, Ethereum saw a 10% increase, and Solana led with a 33% gain over the past week.

Portfolio Pulse from Khyathi Dalal

November 13, 2023 | 10:29 pm

WELL

Welltower has released a business update, providing insights into its current operations and financial health. The update includes information on occupancy rates, revenue trends, and strategic initiatives. Investors are likely to scrutinize this update for signs of growth potential or concerns that may affect Welltower's stock performance.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:25 pm

RDZN

Roadzen reported a significant increase in Q2 revenue, reaching $15.4 million, which represents a 493% rise compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:23 pm

SCYX

SCYNEXIS reported improved financial results for Q3, with EPS at $(0.04) compared to $(0.62) last year, and sales increasing to $1.76M from $1.56M in the same period the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:22 pm

MOTS

Motus GI Holdings (MOTS) reported a Q3 loss of $(4.28) per share and sales of $86.00K, missing the consensus estimate of $120.00K by 28.33%. Sales decreased by 69.06% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:22 pm

HEPA

Hepion Pharmaceuticals has released new efficacy data for Rencofilstat, indicating significant improvements in fibrosis reduction. The results are among the best reported for fibrosis-reducing compounds, potentially positioning Rencofilstat as a leading treatment option in this therapeutic area.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:19 pm

MIGI

Mawson Infrastructure Group Inc. reported a 7% increase in revenue for Q3 2023, reaching $11.3 million compared to the previous quarter.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:16 pm

SAI

SAI.TECH Global reported a 44% year-over-year decline in total revenues for the six months ended June 30, with revenues totaling $3 million.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:13 pm

INVO

INVO Bioscience reported a significant improvement in Q3 with EPS losses decreasing to $(0.70) from $(4.20) YoY, and sales increasing by 314.28% to $974.89K from $235.32K YoY.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:13 pm